Trials / Unknown
UnknownNCT02317224
The Safety and Efficacy of "3-Hole" Subxiphorid Approach in the Treatment of Anterior Mediastinal Tumor
Comparison of Safety and Efficacy Among "3-Hole" Subxiphorid Approach, Trans Sternal Approach and VATS in Surgical Treatment of Anterior Mediastinal Tumor
- Status
- Unknown
- Phase
- Phase 2
- Study type
- Interventional
- Enrollment
- 240 (estimated)
- Sponsor
- Tang-Du Hospital · Academic / Other
- Sex
- All
- Age
- 18 Years – 75 Years
- Healthy volunteers
- Not accepted
Summary
Surgery plays an important role in the treatment of anterior mediastinum disease. The major surgical approaches include: cervical approach, mid-sternal approach, cervical combined mid-sternal approach and video-assisted thoracoscopic approach. The cervical approach is rarely adopted because of its restricted visual field. The cervical combined mid-sternal approach have a broader field of vision, given this advantage, the surgeon can remove the thymus and its surrounding fat tissue more thoroughly. But the trauma of this approach is much larger, and the postoperative complication is also a serious problem. The video-assisted thoracoscope is often adopted by left or right approach, this minimally invasive procedure can not remove anterior mediastinum fat thoroughly. In clinical practice, the investigators designed a new method named "3-Hole" subxiphoid approach. This study is designed to compare the safety and validity between this new method and others.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| PROCEDURE | "3-Hole" subxiphorid and subcostal approach | "3-Hole" subxiphorid and subcostal approach anterior mediastinum tumor resection |
| PROCEDURE | Trans sternal approach | Trans sternal approach anterior mediastinum tumor resection |
| PROCEDURE | VATS approach | Video-assisted thoracoscope anterior mediastinum tumor resection |
Timeline
- Start date
- 2014-08-01
- Primary completion
- 2024-12-01
- Completion
- 2024-12-01
- First posted
- 2014-12-15
- Last updated
- 2014-12-15
Locations
1 site across 1 country: China
Source: ClinicalTrials.gov record NCT02317224. Inclusion in this directory is not an endorsement.